Forma Therapeutics (FMTX) PT Lowered to $54 at SVB Leerink, Following Clinical Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
- Nasdaq ends sharply lower as hot inflation data stirs rate-hike worries
- Oil prices gain on attacks in Saudi Arabia, Iran's new tactics to target tankers
- U.S. consumer prices rise by 3.7% year-on-year in September
- Bank of America stock falls on earnings miss
- Netflix cuts 1,000 jobs as streaming giant seeks to boost engagement
Tweet
Share
E-mailGet Alerts FMTX Hot Sheet
Price: $20.01 --0%
Rating Summary:
2 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 12 | New: 90
Rating Summary:
2 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 12 | New: 90
Join SI Premium – FREE
SVB Leerink analyst Andrew Berens lowered the price target on Forma Therapeutics (NASDAQ: FMTX) to $54.00 (from $65.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JD.com, Inc (JD) PT Lowered to $33 at US Tiger Securities
- Box, Inc. (BOX) PT Raised to Street High $50 at BofA Securities, New Top Pick, 'underappreciated AI winner'
- Norwegian Cruise (NCLH) PT Lowered to $22 at Stifel
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Andrew BerensSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
